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Intra-tumour phenotypic heterogeneity limits accuracy of clinical diagnostics and hampers
the efficiency of anti-cancer therapies. Dealing with this cellular heterogeneity requires adequate
understanding of its sources, which is extremely difficult, as phenotypes of tumour cells integrate
hardwired (epi)mutational differences with the dynamic responses to microenvironmental cues. The
later come in form of both direct physical interactions, as well as inputs from gradients of secreted
signalling molecules. Furthermore, tumour cells can not only receive microenvironmental cues, but
also produce them. Despite high biological and clinical importance of understanding spatial aspects
of paracrine signaling, adequate research tools are largely lacking. Here, a partial differential
equation (PDE) based mathematical model is developed that mimics the process of cell ablation.
This model suggests how each cell might contribute to the microenvironment by either absorbing or
secreting diffusible factors, and quantifies the extent to which observed intensities can be explained
via diffusion mediated signalling. The model allows for the separation of phenotypic responses to
signalling gradients within tumour microenvironments from the combined influence of responses
mediated by direct physical contact and hardwired (epi)genetic differences. The differential equa-
tion is solved around cell membrane outlines using a finite element method (FEM). The method is
applied to a multi-channel immunofluorescence in situ hybridization (iFISH) stained breast cancer
histological specimen and correlations are investigated between: HER2 gene amplification; HER2
protein expression; and cell interaction with the diffusible microenvironment. This approach allows
partial deconvolution of the complex inputs that shape phenotypic heterogeneity of tumour cells,
and identifies cells that significantly impact gradients of signalling molecules.
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2I. INTRODUCTION
Phenotypic heterogeneity of malignant cells within tumours represents a major clinical challenge as it complicates
diagnosis and underpins therapy resistance. This heterogeneity arises as the result of interplay between: a) cell-
intrinsic differences stemming from genetic heterogeneity and stable epigenetically defined states; b) stochastically
arising variability in gene expression; c) environmental inputs in form of physical forces, contact-mediated signals
from neighbouring cells, the extracellular matrix (ECM), and diffusible signals in form of gradients of growth factors,
cytokines, oxygen and metabolites [23]. Understanding exact sources of variability of clinically relevant phenotypic
features is of paramount importance. However, deconvolution of the relative impact of inputs that shape phenotypes
is extremely challenging as we lack appropriate research tools.
When considering anti-cancer therapeutics, the primary issue that has recently emerged is that heterogeneity is
a critical biomarker of tumour prognosis, as greater heterogeneity provides a clear advantage in the face of the
evolutionary bottleneck of anti-cancer therapy — there are simply more paths available to facilitate the generation of
resistance [21]. The design of therapies must consider the existing heterogeneity in a tumour and account for the most
aggressive cells that may exist; and in failing to do so, one may select for pre-existing resistant cells [22]. Furthermore, a
critical generator of phenotypic heterogeneity involves microenvironmental variability within the tumour, as a varying
environment contributes greatly to different modes of adaption, upon spatially organised subgroups of cells [32]. In fact,
it has been shown that heterogeneity of oxygen distribution within a tumour leads to the adaption of subsets of cells
in microenvironmental niches to the hypoxic microenvironment, which has been shown to result in poorer prognosis
and more aggressive tumours [19]. Lastly, heterogeneity has also been implicated as an important consideration in the
field of immunotherapy, where neo-antigen generation is a function of polypeptide heterogeneity, which is a critical
determinant of the success of immunotherapy, and reflects underlying genetic heterogeneity [31].
Microscopy imaging of histological specimens is widely and routinely used in clinical diagnostics of cancers, as well
in experimental studies aiming to understand the underlying biology and responses to anti-cancer therapies. After
fixation and placement on glass slides, tissues are subjected to chromogenic or fluorescent staining using chemical
or antibody-based stains[26]. Staining intensity reflects concentration of the chemical moiety, to which the stain
binds. Therefore, digitisation of chromogenic or fluorescent signals allows quantification of concentration of the these
chemicals. Since histological slides retain spatial information, they are suitable for the analysis of not only cellular
phenotypes and genotypes, but also microenvironmental factors that shape cellular heterogeneity [15]. Statistical
approaches have been focused on the task on feature extraction, feature selection, and dimension reduction of large
histological images. This field is sometimes known as whole-slide imaging (WSI). Feature extraction can happen at
both at, a pixel-level, largely uninterpretable by a human (e.g., pixel intensities compared to neighbours), and at
an object-level, recovering features that a pathologist would naturally be interested in (e.g., circularity of cell nuclei,
location of blood vessels). Feature selection (along with the preceding staining procedure) can be carried out depending
on the histopathology of the specific disorder, or based on dimensionality reduction (e.g., using principle component
analysis) and irrelevant features can be ignored. Feature analysis is a statistical/machine learning problem, where the
aim is to link the collective cell (or pixel) properties to macroscopic disorders/clinical outcomes [13]. Modern trends
include considering ecologically motivated spatial statistics [15, 25]. Histology analysis is both cheap and also highly
clinically relevant, and a pathologist can diagnose based off an image. However, a histology slide is static and one is
seldom able to elucidate any mechanism underlying observations.
Using mathematical modelling, we present a quantitative approach to calculate how each cell alters the local
microenvironment using only histological images. Our approach allows us specify two things. First, to what degree
a cell is either absorbing from, or secreting into, a local diffusible signalling environment; and second, how much of
the observed staining intensities are explainable via diffusion. Therefore, when one stains a histology slide to measure
the expression of a specific protein, one is then able to quantify the extent to which that protein contributes to
microenvironmental signalling. The method presented is based on postulating that expression levels (as determined
by staining intensity) of targets of analyses are determined by an effect of a field of secreted environmental signalling
molecules. This signalling field (SF) abstraction integrates all of the secreted factors that impact the expression of
a particular phenotypic trait in a paracrine manner (cytokines, gases, metabolites). Our approach ignores physical
interactions between cells (e.g., force interactions through the ECM) and relies on availability of multi-channel staining
data.
Substantial mathematical modelling efforts have been focused on understanding the impact of the microenviron-
ment on phenotypic heterogeneity using biophysical principles; common themes include diffusion of cytokines, and
construction of chemical reaction networks. Efforts at modelling the microenvironment in a spatial setting have largely
been focused on forward modelling, where one makes assumptions and rules for a model, initiates the model in some
starting configuration, and then evolves it forward in time. Due to the complexity of the models involved, cellular
automata approaches have often been utilised [3–5, 8, 30]. Such approaches, depending on the complexity of the rules
built into the model, are able to reproduce many experimental/clinical observations, and in some cases are capable of
3making experimentally validated predictions [6]. Unfortunately, mathematical modelling approaches are limited by:
the frequent need for model iteration, where model components are added and removed; the complexity of rules needed
to describe the behaviour of biological systems, such that underlying assumptions may often be untestable; and the
experimental difficulty of obtaining relevant measurements required for adequate parametrisation of the underlying
mathematical model. Our method should aid with future modelling as then one can “rule in” critical determinants.
Our approach is centred on mimicking the process of ablation within the fields of neuroscience [9, 34, 36] and
embryonic development [7]; this is where one kills or disables a single neuron to observe how the remaining system
behaves. Each cell is considered a functional unit that changes the SF from an implied baseline value, to the observed
value of the staining intensity. The baseline value we calculate as the SF at the cell’s location were the cell not
present ; this calculation is performed by solving a steady state diffusion equation (Poisson’s equation) with decay.
Since parameter estimation is likely impossible, we calculate the signal staining intensities that we expect based on
the postulate of all of the variability coming from the impact of the signalling field. We then compare the expected
(baseline) staining intensity of each cell with the experimentally measured (observed) values. Differences between the
baseline and observed values are interpreted as cell impact : how a cell alters the SF. We test applicability of our
approach using histological samples of breast cancer.
The paper is structured as follows: in Section II, we present the mathematical details behind our method in-
cluding: assumptions made and parameter selection. Section III discusses our method applied to a multi-channel
immunofluorescence in situ hybridization (iFISH) stained breast cancer data set, in which HER2 gene and HER2
protein expression were studied concurrently. Section IV lays out a toy problem to demonstrate our approach when
one uses artificially generated data. In Section V, we conclude and discuss potential future work.
II. METHOD APPLIED TO PARACRINE SIGNALLING
Our approach consists of two stages: a mathematical modelling step (Section IIA), and a parameter selection
step (Section II B). We first pose a class of diffusion models governed by partial differential equations (PDEs) for the
description of SF in the extracellular space. This class of models has a number of free parameters: the effective diffusion
constant; the rate of decay and the type of boundary condition posed on the cell surfaces. We then consider model
selection by asking: what is the discrepancy between the expression of target being analysed (the observed staining
intensity) and the expected SF were the cell absent from the histological slide (the baseline staining intensity). Using
the assumption that the SF should account for most of the variance in signal that the cell produces, we carry out
model selection over the space of possible model parameterisations. Finally, we then have a baseline staining signal
intensity and an observed signal intensity for each cell.
A. Mathematical Modelling
To model paracrine signalling, we assume that cells communicate via a diffusible species present in the extracellular
domain called the Signalling Field (SF), with concentration profile u = u(x), which degrades at rate λ > 0. Cells are
stained with a probe that binds internally, the chromogenic or fluorescent intensity is not necessarily representative
of the SF; however we specify that production of the SF is linearly related to the stain intensity. We do not model
other signalling processes such as direct signalling or forces exerted between cells via direct contact (such as adherent
or gap junctions) or indirect contact via the ECM.
A histology slide is a 2-dimensional slice though a 3-dimensional tissue. In reality, the cells visible on this slide
would be interacting with cells above and below the side (before sectioning the tissue). However, for the purposes of
our reconstruction we consider only cells visible in the slide, and consider the signalling field to diffuse in 2-dimensions
only. In principle a 3-dimensional analysis could be performed by considering multiple adjacent pathology slides.
We consider N non-overlapping cells labelled i ∈ N = {1, . . . , N} that occupy volumes Di ⊂ R2 [27] (see Figure
1(a)), so that extracellular domain is Ω = R2 \ ⋃Ni=1Di. We consider the case in which the timescale of diffusion
is faster than any other timescale of interest so that the SF is in steady state. The concentration profile u is then
governed by
∇2u− α2u = 0 in Ω , (1)
where α2 = λ/κ and κ > 0 is the diffusion coefficient.
We suppose that the production/absorption of the SF is proportional to the difference in the average cellular stain
intensity ci (averaged over the cell) and the concentration of the SF at the cell boundary. Thus we write [28]
ni · ∇u = γ(ci − u) on x ∈ ∂Di . (2)
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Figure 1. Mathematical idealisation of cells on a pathology slice. (a.) Original domain Ω, and (b.) modified domain Ωi = Ω ∪ Di.
The parameter γ ∈ (0,∞) is a measure of how strong the cellular response is to a difference between the local SF
field and the “target” value ci. When γ = 0, the cell does not react to the signalling field at all; as γ → ∞ the cell
actively absorbs/secretes the SF as fast as it needs to in order to maintain the interior of the cell at the fixed observed
staining intensity ci.
The problem defined by equations (1)–(2) is well-posed and would allow us to recreate the extracellular SF were
parameters (α, γ) known. However, it was our aim to learn how each cell modifies the SF. To this end, for each cell
i ∈ N , we will determine the difference between the observed staining intensity (ci) and the expected signal were the
cell not present. Therefore, we define a new SF problem with cell i removed. Denoting the resulting concentration
profile by ui, we then have
∇2ui − α2ui = 0 in Ωi , (3)
and Ωi = Ω ∪ Di = R2 \
⋃
j 6=iDj . Thus the SF now diffuses in the region occupied by cell i also; the boundary
conditions on the remaining cells stay the same
nj · ∇ui = γ(cj − ui) on x ∈ ∂Dj , (4)
for all j = 1, . . . , i− 1, i+ 1, . . . , N . The domain for the modified problem is illustrated in Figure 1(b). The problem
is also well posed (see Appendix A). The baseline SF were cell i not present is then defined as the mean value of the
SF over the cell
bi :=
1
|Di|
∫
Di
ui(x)dx . (5)
We could also average over the cell boundary, however this gives no difference in results qualitatively. We define the
cell impact to be
fi := ci − bi , (6)
which can be interpreted as follows: if fi > 0, the cell is secreting factors locally into the SF; and if fi < 0, then the
cell is absorbing factors from the SF.
We solve the PDE systems (3)–(4) using a finite element method; see Appendix B for details.
B. Parameter Selection
Parameter selection is the biggest challenge to implementation of our method. For metabolic processes, diffusion
constants and decay rates are frequently known, for example, oxygen, glucose, etc. However, in our case, the specific
5chemicals comprising the signalling field are unknown (we note again that this is not the chemical stained for, but a
hypothesised downstream factor).
Rather than trying to estimate ~p = (α, γ) from experiments, we choose ~p to give a best fit to the data in the
following sense. For each stain, we measure the observed staining intensities for each cell ~c = {c1, . . . , cN}. For
a fixed set of model parameters ~p, the method described above can be used to generate the baseline intensities
~b = {b1(~p), . . . , bN (~p)}.
We then choose parameters ~p∗ such that the coefficient of determination (denoted R2) is maximised, i.e.,
~p∗ = arg max
~p=(α,γ)
R2 , (7)
where
R2 = 1−
∑N
i=1(ci − bi)2∑N
i=1(ci − c¯)2
, (8)
with
c¯ =
1
N
N∑
i=1
ci . (9)
The coefficient R2 measures the fraction of the variance of the stain intensities that can be accounted for by our
signalling field model.
III. EXPERIMENTAL DATA
We apply our approach to the analysis of breast cancer tissue sections stained with nuclear stain DAPI that reflects
cellular DNA content, and two important proteins targets:[29] HER2 , a receptor tyrosine kinase that is amplified in
subset of breast cancers and is considered to be a potent ‘driver’ gene [24], and Oestrogen Receptor (ER), a nuclear
receptor that mediates cellular response to oestrogen signalling. Both HER2 and ER staining are expected to have
profound influence on cells phenotypes. Additionally, using fluorescence in situ hybridization (FISH), data regarding
the amplification status of the HER2 gene is available.
The data used collected in compliance with the Declaration of Helsinki and was approved by the regional ethics
committee (REK S-06495b) and the institutional review board of Oslo University Hospital Radiumhospitalet (IRB
2006-53). Full details of the experimental protocol can be found in Refs. [2, 33].
The cell outlines were found using the GoIFISH software [33], the pixels that formed the cell outlines were down
sampled by a factor of 8, so that the cell edges were given by polygons. For the FEM scheme, nodes within domain Ω
were placed using Halton node placing [12]. To simplify parameter searches in γ ∈ (0,∞) (which crosses many orders
of magnitude) we mapped it to the bounded variable β = γ/(γ + 1) ∈ (0, 1).
From the method in Section II, we maximise R2 given in equation (8) for each of the 3 stains for 3 histology slides.
The corresponding values of α∗ and γ∗ are found in Table I. From Table I, we see that the R2max is small for DAPI
as expected: DNA content should be independent of diffusible signalling components. In contrast, for the HER2 and
ER stains, Table I suggests that the majority of the variance in the observable data set can be explained by SF.
Note that the large values of γ∗ indicate a strong coupling between the HER2 staining intensity and the SF. It is
reassuring that R2max and α∗ are similar for the same stain across different slides. The range of values of γ∗ are less
consistent.
Stain Region Sample 1, N = 479 Sample 2, N = 381 Sample 3, N = 524
α∗ γ∗ R2max α∗ γ∗ R
2
max α∗ γ∗ R
2
max
DAPI Nucleus 0.008 0.15 17% 0.006 0.04 12% 0.006 0.05 21%
HER2 Membrane 0.000 ∞ 61% 0.023 ∞ 60% 0.010 6.75 67%
ER Nucleus 0.012 0.14 51% 0.012 1.11 45% 0.003 0.07 50%
Table I. Maximum variance reduction possible for each stain and corresponding parameters for BCA data set.
In Figure 2, we plot the observed, baseline and cell impact spatial staining patterns for the DAPI , HER2 and
ER stains for sample 1. Additionally, we also plot the solution to equation (1) using the ~p∗ parameter set (without
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Figure 2. Pathology slide with outlines plotted. Figures showing stain intensity for: (left column) observed intensities ~c; (left centre
column) the exterior signalling field — the solution to equation (1); (right centre column) baseline intensities ~b; (right column) cell impact
~f — for this column red colours correspond to secreting cells, blue colours correspond to absorbing cells. The rows correspond to: (top
row) DAPI stain; (middle row) HER2 stain; and (bottom row) ER stain.
removing any cells). This allows us to visualise the hypothesised SF. Plots relating to the same stain use the same
scaled colour bar. The general trend one finds is that the observed data set is very heterogeneous with regards to
staining intensity, the baseline data set looks like a smoothed version of the observed data set, and the cell impact
data set shows variations around the baseline.
A. Possible Identification of Microenvironmental Niches
For Sample 1, ignoring the DAPI stain, we plot the baseline HER2 and baseline ER data sets as a scatter graph in
Figure 3(a). One observes approximately 3 clusters of points (which can be found using k-means clustering). When
looking at the observed staining intensities, these clusters of points appear as less distinct entities, see Figure 3(b). An
interpretation of this finding is that there are 3 distinct microenvironmental niches on the slide. Viewing these clusters
spatially, one can see that cells with approximately the same microenvironment are located in adjacent locations, see
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Figure 3(c). Samples 2 and 3 seemed to also have niches, but without such immediately identifiable groups.
B. Use of Centromeric Probes to Investigate HER2 Gene Amplification Status
Using the FISH experimental procedure, a HER2 gene specific probe was used in conjunction with a centromeric
probe to identify the copy number of the HER2 gene for each cell. We write the copy number of cell i as
Ai =
BAC
CEP
=
# Number of HER2 gene probes detected
# Number of centromeres detected
. (10)
As the data is noisy, we discard data points that are biologically unreasonable, i.e., correspond to a amplification
ratio that is infinite (Ai =∞), or less than a single specific probe detected per centromere (Ai < 1). We then put the
data into two ordinal sets, either unamplified wildtype (WT) cells where the HER2 gene has not been upregulated
(Ai = 1), or where the cell has amplified the HER2 gene (Ai > 1). For the 3 data sets, after invalid data has been
discarded, amplified HER2 cells account for 26%, 9% and 17% (respectively) of the cells on the slide.
For the first data set, using a logistic regression, one can use the measured HER2 staining intensities ~c to predict
whether the HER2 gene is amplified ~A = {A1, . . . , AN}. This logistic regression is correct with 66% accuracy.
Analysing the binary classified data sets for staining intensity (either low or high staining intensity with the threshold
determined by the logistic regression), we find that for high staining intensity cells tend to be net secretors of the SF
(fi > 0), and cells with low staining intensity tend to be net absorbers of the SF (fi < 0).
However, when looking at cells with low HER2 staining intensity, but with amplified HER2 gene, we find that the
cell impact for the HER2 stain is greater than the mean for all low HER2 stain intensity cells (see Figure 4). By
use of z-tests (used for n > 30 samples), we reject the null hypothesis that: the mean cell impact for cells with low
HER2 stain intensity and amplified HER2 gene is the same as the population mean cell impact for all cells with low
HER2 stain intensity ; compared to the alternative hypothesis that the means are not the same. This is found to be
statistically significant with p < 0.05. The interpretation of this is that when cells have a low staining intensity, but
with an amplified HER2 gene, the cells may not necessarily stain brightly but are net secretors into the SF, (and
therefore they likely stain comparatively more intensely than their immediate neighbours).
Additionally, it should be noted for cells with low staining intensity: for amplified HER2 copy number, cells are
net producers of the SF impacting ER intensity; and for unamplified HER2 cells, cells are net absorbers of the SF
impacting ER intensity (for both cases using z-tests, p < 0.05).
IV. METHOD MOTIVATION VIA TOY SYSTEM
In this section we evaluate the efficacy of our method on synthetic data (where we know the exact mathematical
representation of the heterogeneity). We generate this data with the following simple model. For each cell i, we
suppose that there is measurable quantity yi = yi(t) corresponding to the staining intensity. We suppose that there
are a number of cell phenotypes, labelled by τ in set T . We suppose that a each cell produces a signalling field from
other cells as well as to some internal dynamical system within the cell. Thus we write
dyi
dt
= µi(yi) + φi(yi, u) . (11)
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Here µi represents the internal dynamics, and will account for the cell’s phenotype τ , and φi represents the forcing by
the signalling field u. As before we suppose that the dynamics of yi are slower than the diffusion of the SF, so that u
is in quasi-steady state. In the method described in Section II, this had the form
φi(yi(t), u(x)) =
β
|Di|
∫
∂Di
(u(x)− yi(t)) dS , (12)
where β is a scaling constant with units length over time, and u = u(x) obeys equations (1)–(2). The baseline was
then found by considering the average concentration at the cell’s location were the cell not there.
For simplicity, in our synthetic system, we will consider cells occupying negligible area, i.e, they will behave as
point sources/sinks of the SF — and therefore we do not need to incorporate boundary conditions. In this case, the
baseline (bi) can be calculated by removing the internal dynamics for cell i, i.e., by setting µi = 0.
With cells as points, we take φi as the Green’s function solution to equation (1)–(2). Thus,
φi = β
∑
j 6=i
Gn(dij , α) [yj(t)− yi(t)] , (13)
where dij represents the distance between cells i and j. The form of Gn depends on the dimension, and is given by
Gn(r, α) =
{
K0(αr)/2pi if n = 2 ,
e−αr/4pir if n = 3 ,
(14)
where K0 is the modified Bessel function of the second kind. The baseline is then given by
bi =
∑
j 6=i
cj Gn(dij , α)
/∑
j 6=i
Gn(dij , α) . (15)
Notice that as cells are points, there is no γ parameter (though in some sense it has been replaced by β).
We specify that there are three cell phenotypes τ ∈ T = {1, 2, 3}. We take N = 3000. 1500 cells are placed
uniformly at random in the unit circle; 1500 cells are placed uniformly at random in the annulus between r = 1 and
r = 2 (see Figure 5). Using k-means clustering, cells are assigned into 15 groups. Groups are then assigned a cell
type label randomly so that there are 5 groups of each cell type. The internal dynamics of each cell type are chosen
to be given by
µi(yi) =

i/4− yi if τi = 1 ,
0 if τi = 2 ,
1 + i/4− yi if τi = 3 ,
(16)
and we use the 3 dimensional Green’s function as the interaction term. Here i is a random number drawn from
i ∼ N (0, 1) and is the means by which we model heterogeneity within a fixed cell phenotype. We choose β = 4pi/N
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Figure 5. Plots relating to toy model. (a,e.) Plot of observed cell intensities, and corresponding histogram of intensities. (b,f.) Plot
of simulated cell locations, now marked red or blue according to cell phenotype, and histogram now broken up by cell phenotype. (c,g.)
Plot and histogram of baseline cell intensities. (d,h.) Plot and histogram of cell impact intensities. For the simulation shown, α∗ = 10.91,
R2max = 79%. Using k-means clustering on the 3 data sets (~c, ~b, ~f), cell phenotypes are correctly identified with: 79% (~c), 84% (~b), and
13% (~f) accuracy.
and α = 10. We can interpret the cell phenotypes as: cell phenotype τ = 1 is a cell that averages the signal received
by neighbours to settle at a steady state close to some intrinsic value i/4; cell phenotype τ = 2 is a passive cell that
mimics nearby cells; and cell phenotype τ = 3 is a cell that averages the signal received by neighbours to settle at a
steady state close to some intrinsic value 1+i/4. From random initial conditions in the unit interval (yi(t = 0) ∈ [0, 1]),
the system will reach a steady state. The functional forms chosen are such that there is considerable overlap in the
distribution of steady states for each cell phenotype, so that it is not immediately clear which phenotype a cell belongs
to given the steady state value ci.
In Figures 5(a,e), we see a spatial plot of the cell centres and a histogram of the observed intensities (~c); Figure 5(b,f)
reveals the discrete cell phenotypes that are not immediately apparent when viewing Figures 5(a,e). To calculate the
baseline (~b), we assume the functional form of the interactions are as in equation (13), but without specifying the value
of α, which is determined via a best fit as in Section II B. In Figure 5(c,g), we show a spatial plot and histogram of
the baseline cell intensities; and in Figure 5(d, h) we show the cell impact cell intensities. From Figure 5(f) to Figure
Figure 5(g), we see the emergence of a trimodal distribution indicating the three cell phenotypes. The phenotype
τ = 2 is easily identified in Figure 5(h) as the population having zero cell impact : this is to be expected since these
cells essentially copy what their neighbours are doing.
Over 1000 simulations, we find that α∗ has a mean value of 11.49 [95% CI: (8.65, 14.46)], and R2max has a mean
value of 79.6% [95% CI: (76.9%, 82.3%)]. Carrying out k-means clustering on ~c, ~b and ~f using a priori knowledge
that there are 3 phenotypes present, one finds that on average one identifies the 3 groups with 70.2% [using ~c, 95%
CI: (49.9%, 82.5%)], 74.3% [using ~b, 95% CI: (57.4%, 87.3%)], and 15.7% [using ~f , 95% CI: (11.0%, 20.1%)] accuracy
respectively. Therefore, one can obtain slightly higher accuracy by looking at the baseline intensities rather than the
stain intensities. Moreover, if we identify the passive τ = 2 cells using fi ≈ 0, see Figure 5(h), then the remaining
cells can be clustered into 2 groups with approximately 100% accuracy.
With β = 2pi/N , the 2 dimensional Green’s function performs with similar accuracy regarding R2max values and
clustering analysis. However, the α∗ value is misidentified with mean value 16.66 [95% CI: (12.87, 20.79)].
V. DISCUSSION
We have presented a method to identify and extract diffusible microenvironment signalling from histology slides.
We are also able to quantify what percentage of the data is explainable by diffusion mediated signalling. We applied
our method to breast cancer histology slides and found that HER2 amplified cells with low HER2 stain intensity
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have higher a higher cell impact than the population of all low HER2 stain intensity cells. Finally the method was
evaluated on synthetic data generated by a simpler model for cell behaviour.
This initial study suggests a methodology that could be applied to more general problems. For example mechan-
otransduction is another important method of cellular communication [16], to which our simulated ablation approach
could be applied.
A. Method Applicability
In our analyses of clinical samples, we used stains for proteins where we are unsure of the exact sources behind
variation in stain intensity, be that genetic, microenvironmental, or stochastic. HER2 amplification is widely believed
to be a genetic event and should be heritable. Expression levels of HER2 protein are expected to reflect the gene
amplification status. On the other hand, some experimental evidence shows HER2 expression might reflect not
only genetic material, but also microenvironmental stimuli, such as Notch and NF-κB (RANK) signalling (with the
effect of increased HER2 transcription and regulation of the expansion of cancer stem cells) [17, 18, 20, 38]. The
interpretation of the R2max values should be as what is the maximum percent of the signal variance explainable via
our model of cellular communication for paracrine signalling. Therefore, our method can potentially reveal paracrine
interaction even in scenarios where variability of the analysed trait is primarily believed to reflect genetic differences.
Due to this work being only a preliminary study, the presented analysis should be viewed as a promising first step
and demonstration of the method, rather than bona fide proof of principle. We envision that the method presented
here will be directly applicable to defined scenarios of biological and clinical importance. For example, paracrine
signalling is responsible for microenvironment-directed therapy resistance against most of the targeted anti-cancer
therapies used in clinics [35]. Yet, the signalling fields as well as impact of individual cells on them have not been
studied due to the lack of appropriate tools. For example, the method could be used to interrogate the spatial
distribution of c-MET phosphorylation, implied in resistance to ALK targeting tyrosine kinase inhibitors in non-small
cell lung cancers [35, 37], as c-MET phosphorylation should be reflective of microenvironmental gradients of its ligand
HGF, which is primarily produced by cancer-associated fibroblasts.
A clear next step to promote use and acceptance of our method would be to see how our method performs against
different types of cancer stained under the same protocol. Particularly, it may be of particular interest to investigate
cancers that are known to be genetically homogeneous, and so the majority of the variance in observation may come
from diffusion. In contract, one could investigate genetically heterogeneous cancers and therefore proportionally less
variance may be accountable by diffusion. Additionally, it would be particularly pertinent to design experiments
where stains relating to metabolic activity were selected. Cell types are usually identifiable by eye, and our approach
may even aid hypothesis of cell function.
B. Data Limitations
Clearly our method as it stands suffers many drawbacks. Regarding use of data, we are stuck working in two
dimensions. Working in three dimensions using complete reconstructions of cell geometry would be possible; however,
this would be expensive and not repeatable in a clinical setting.
There will also be edge effect artefacts that we have not accounted for in the model. By this, we mean there will
be cells that impact the SF, but were excluded by the biopsy extraction and preparation process. One option is to
decrease sample sizes by ignoring a layer of cells at the edge of the histology slice.
When considering the data set used in Sections III, for our method to “pick out” important features of the data, we
recommend that R2max & 40% at a minimum.
C. Technique Refinement
It is likely that other methods for parameter selection are also worthy of exploration. For example, one could also
make the opposite assumption: that the contribution of genetic heterogeneity is large, and the microenvironment
minimally contributes to the observed data set ~c — however this does not work practically as then one could then
either set α → ∞, or γ = 0 and then bi = 0 and ‖~c − ~b‖ is maximised. Constraints have to be introduced in an
intelligent manner.
Our model could also be expanded to include different classes of objects, for instance, it would not be difficult to
include blood vessel structures. Additionally, were it the case that a cell was stained multiple times and one had an
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a priori knowledge for how a cell was supposed to function, relevant constraints could be included in the parameter
selection method. In this paper, we did not carry out an exhaustive search on parameter selection techniques.
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Appendix A: Existence and Uniqueness
The original problem is stated as equations (3)–(4) for each i ∈ N . Without any loss of generality, we can solve
equations (1)–(2). Written out again, this is
∇2u− α2u = 0 in Ω ,
ni · ∇u = γ(ci − u) on ∂Di . (A1)
We specify that ∂Di is C1 regular, and we prove the existence and uniqueness of u in H1(Ω) — although the solution
is likely smoother.
The question whether we have to impose a limit condition of the form lim‖x‖→∞ u(x) = 0 is a priori unclear.
Intuitively, if we impose such a condition, it has to be zero, since the dissipation term would mean a null concentration
at an infinite distance of the source. In fact, we will not have impose this, as the unique solution of (A1) is zero at
infinity, due to the dissipation.
Let us recall that the Sobolev space W pm(Ω) is the space of function defined as follows
W pm(Ω) = {u ∈ Lp(Ω) |Dβu ∈ Lp(Ω) ,∀β ≤ m} . (A2)
Here we will be particularly focused on the Hilbert space H1(Ω) = W 21 (Ω) endowed with the H1 norm defined by
‖v‖H1(Ω) = ‖v‖L2(Ω) + ‖∇v‖L2(Ω) , ∀v ∈ H1(Ω) . (A3)
Proposition A.1. The problem (A1) has a unique solution in H1(Ω).
Proof. The weak formulation of the problem (A1) given by
a(u, v) = l(v) , ∀v ∈ H1(Ω) , (A4)
for
a(u, v) =
∫
Ω
∇u(x) · ∇v(x)dx + α2
∫
Ω
u(x)v(x)dx + γ
∫
∂Ω
u(x)v(x)dS , ∀u, v ∈ H1(Ω) , (A5)
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and
l(v) = γ
∫
∂Ω
ψ(x)v(x)dS , ∀v ∈ H1(Ω) , (A6)
where ∂Ω =
⋃
i ∂Di and ψ is a function satisfying
ψ(x) = ci when x ∈ Di . (A7)
We now aim to prove continuity and coercivity of a(u, v) on H1(Ω), as well as the continuity of l(v) on H1(Ω) to
satisfy the Lax–Milgram Theorem (Theorem 5.8 on page 83 in [14]). Specifically, we wish to show that
Continuity of a(u, v)⇐⇒∃A > 0 s.t. |a(u, v)| ≤ A‖u‖‖v‖ ,
Coercivity of a(u, v)⇐⇒∃B > 0 s.t. |a(u, u)| ≥ B‖u‖ , (A8)
Continuity of l(v)⇐⇒∃C > 0 s.t. |l(v)| ≤ C‖v‖ .
Continuity of a(u, v)
For u, v ∈ H1(Ω), by nature of the modulus function, one can immediately write following inequality
|a(u, v)| ≤
∣∣∣∣∫
Ω
∇u(x) · ∇v(x)dx
∣∣∣∣+ α2 ∣∣∣∣∫
Ω
u(x)v(x)dx
∣∣∣∣+ γ ∣∣∣∣∫
∂Ω
u(x)v(x)dS
∣∣∣∣ . (A9)
The Cauchy-Schwartz inequality allows us then to write
|a(u, v)| ≤ ‖∇u‖L2(Ω)‖∇v‖L2(Ω) + α2‖u‖L2(Ω)‖v‖L2(Ω) + γ‖u|∂Ω‖L2(∂Ω)‖v|∂Ω‖L2(∂Ω). (A10)
According to the Trace Theorem [11], since u, v ∈ H1(Ω) and because Ω is C1 and ∂Ω is bounded, then u|∂Ω, v|∂Ω ∈
H
1
2 (∂Ω) and the Trace operator is continuous from H1(Ω) to H
1
2 (∂Ω). So, there exists a positive constant C such
that
‖u|∂Ω‖H 12 (∂Ω)‖v|∂Ω‖H 12 (∂Ω) ≤ C
2‖u‖H1(Ω)‖v‖H1(Ω). (A11)
According to the Sobolev Embedding Theorem [39], for an open set U ∈ RN , Wm,p(U) ⊂ Lq(U),∀1 < q < ∞ if
mp = N , which is the case here for U = ∂Ω, m = 12 , p = 2 and N = 1. Moreover, this injection is continuous and
then, for all 1 < q <∞, there is a positive constant Dq such that
‖u|∂Ω‖Lq(∂Ω)‖v|∂Ω‖Lq(∂Ω) ≤ D2q‖u|∂Ω‖H 12 (∂Ω)‖v|∂Ω‖H 12 (∂Ω). (A12)
Therefore, using (A11) and (A12), we can write
‖u|∂Ω‖Lq(∂Ω)‖v|∂Ω‖Lq(∂Ω) ≤ C2D22‖u‖H1(Ω)‖v‖H1(Ω). (A13)
From this inequality, we can write (A10) as follows
|a(u, v)| ≤ ‖∇u‖L2(Ω)‖∇v‖L2(Ω) + α2‖u‖L2(Ω)‖v‖L2(Ω) + γC2D22‖u‖H1(Ω)‖v‖H1(Ω) , (A14)
Because ‖∇u‖L2(Ω)‖∇v‖L2(Ω) ≤ ‖u‖H1(Ω)‖v‖H1(Ω) and ‖u‖L2(Ω)‖ v‖L2(Ω) ≤ ‖u‖H1(Ω)‖v‖H1(Ω), then the following
inequality can be deduced from (A14)
|a(u, v)| ≤ (1 + α2 + γC2D22)‖u‖H1(Ω)‖v‖H1(Ω) , (A15)
allowing to conclude that the bilinear form a(u, v) is continuous on H1(Ω).
Coercivity of a(u, v)
Let us prove now the coercivity of a. Let u ∈ H1(Ω). We can write
|a(u, u)| = ‖∇u‖2L2(Ω) + α2‖u‖2L2(Ω) + γ
∫
∂Ω
[u(x)]2dS . (A16)
Since the term γ
∫
∂Ω
u2dS is positive, then
|a(u, u)| ≥ ‖∇u‖2L2(Ω) + α2‖u‖2L2(Ω) , (A17)
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and therefore
|a(u, u)| ≥ min(1, α2)‖u‖2H1(Ω) , (A18)
which proves the coercivity of a(u, v).
Continuity of l(v)
Let v ∈ H1(Ω), we can immediately write the following inequality
|l(v)| ≤ γ
∫
∂Ω
|ψ(x)v(x)|dS . (A19)
Because the function ψ is bounded on Ω, we can write
|l(v)| ≤ γ‖ψ‖L∞
∫
∂Ω
|v(x)|dS , (A20)
which can be written
|l(v)| ≤ ‖ψ‖L∞‖v‖L1(∂Ω) . (A21)
Using again the Trace Theorem [11], since v ∈ H1(Ω), we know that there exists a positive constant C such that
‖v|∂Ω‖H 12 (∂Ω) ≤ C‖v‖H1(Ω) . (A22)
According once more to the Sobolev Embedding Theorem [39], there is a positive constant Dq such that
‖v|∂Ω‖Lq(∂Ω) ≤ Dq‖v|∂Ω‖H 12 (∂Ω) . (A23)
Therefore, using (A22) and (A23), we can write
‖v|∂Ω‖L1(∂Ω) ≤ CD1‖v‖H1(Ω) . (A24)
Then we can write (A21) as follows
|l(v)| ≤ γCD1‖ψ‖L∞‖v‖H1(Ω) , (A25)
which proves the continuity of l on H1(Ω). Then the Lax–Milgram Theorem [14] ensures that the problem (A4) has
a unique solution u on H1(Ω).
Remark A.1. The previous proof does not work for the particular case γ = 1, which corresponds to a Dirichlet
condition imposed on the surface of each cell. The proof of existence and uniqueness in this particular case would need
to proceed differently. This case can be treated in defining the closed and convex set K = {v ∈ H1(Ω) | v−ψ ∈ H10 (Ω)}
and applying the Stampachia Theorem [10].
Appendix B: Numerical Approach
Due to the geometrical effects involved in this problem, we use a Finite Element Method (FEM) approach. For a
practical guide to implementation, see Ref. [1], and a theoretical guide to elliptic PDEs, see Ref. [14]. In weak form,
our problem is for cell i removed on domain Ωi = Ω∪Di = R2 \
⋃
j 6=iDj . For ui, v ∈ H1(Ωi), we have the weak form
problem ∫
Ωi
∇v(x) · ∇ui(x)dx + α2
∫
Ωi
v(x)ui(x)dx + γ
∫
∂Ωi
v(x)ui(x)dS = γ
∫
∂Ωi
v(x)ψi(x)dS , (B1)
where ψi = ψi(x) is any function that satisfies
ψi(x) = cj when x ∈ D¯j , (B2)
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for j = 1, . . . , i− 1, i+ 1, . . . , N . We use a standard continuous Galerkin method with piecewise linear basis functions
{ηk(x)}Kk=1 on the triangulation of Ωi, T = T (Ωi). For a triangle T with vertices (t1, t2, t3), and the kth basis function
being located at vertex t1, ηk is given as
ηk(x, y) =
1
2|T | det
 1 x y1 xt2 yt2
1 xt3 yt3
 , ∀(x, y) ∈ T , (B3)
for
|T | = Area(T ) = 1
2
det
 1 xt1 yt11 xt2 yt2
1 xt3 yt3
 , (B4)
and ηk(x, y) = 0 for (x, y) 6∈ T . Therefore
ηk(xl, yl) = δkl , for k, l = 1, . . .K . (B5)
Replacing v by the lth basis function ηl and expanding ui as the sum
ui =
∑
k
akηk , (B6)
we obtain a linear system of equations (
L+ α2D + γR
)
a = γr , (B7)
and we solve for a. Notice that changing constants (α, γ) do not require reassembly of matrices. The matrix entries
are given as follows: the Laplacian matrix L is given by
Lkl =
∫
Ωi
∇ηk(x) · ∇ηl(x) dx ; (B8)
the exponential decay matrix D is given by
Dkl =
∫
Ωi
ηk(x) ηl(x) dx ; (B9)
and the robin boundary condition comes in two parts, first the matrix R,
Rkl =
∫
∂Ωi
ηk(x) ηl(x) dS , (B10)
and then the vector r with entries
rk =
∫
∂Ωi
ηk(x)ψi(x) dS . (B11)
Within this finite element framework, calculating the baseline is then
bi =
∑
T∈T (Di)
∫
T
akηk(x)dx , (B12)
=
∑
T∈T (Di)
|T |
3
[at1 + at2 + at3 ] . (B13)
Calculating these inner products between basis functions can be challenging. We now give a practical guide to
implementation.
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1. Practical Approach to FEM Implementation
To practical implement our FEM scheme, instead of putting in the entries to the matrices L,B,R and vector b in
individually, it is much simpler to do it each triangle or boundary edge at a time. We write L and B as a sum over
the triangles T in the triangulation T (Ωi)
L =
∑
T∈T (Ωi)
L(T ) , (B14)
D =
∑
T∈T (Ωi)
D(T ) . (B15)
The entries of L(T ) are given as
L
(T )
kl =
{
L˜
(T )
tk,tl
if vertices (k, l) are part of triangle T
0 otherwise
}
, (B16)
and analogously for D(T )
D
(T )
kl =
{
D˜
(T )
tk,tl
if vertices (k, l) are part of triangle T
0 otherwise
}
, (B17)
and therefore L˜ and D˜ are 3× 3 matrices. These matrices have well known analytic solutions given as
L˜ =
|T |
2
GG† , (B18)
for
G =
 1 1 1xt1 xt2 xt3
yt1 yt2 yt3

−1 0 01 0
0 1
 , (B19)
and
D˜ =
|T |
12
 2 1 11 2 1
1 1 2
 . (B20)
For matrix R and vector r, we sum over edges E that form the discretised boundary E(∂Ωi)
R =
∑
E∈E(∂Ωi)
R(E) , (B21)
b =
∑
E∈E(∂Ωi)
b(E) , (B22)
where
R
(E)
kl =
{
R˜
(E)
ek,el if vertices (k, l) are part of edge E
0 otherwise
}
, (B23)
and therefore R˜ is a 2× 2 matrix given as
R˜ =
|E|
6
(
2 1
1 2
)
, (B24)
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for |E| = Length(E) = ‖xe1 − xe2‖. Similarly for entries of vector r
rk =
{
r˜
(E)
ek if vertex k are part of edge E
0 otherwise
}
, (B25)
and therefore
r˜k =
|E|
2
ψi(xe) . (B26)
